Dr. Nicholas Andrew Battista, MD

Dr. Battista practices at CHI St. Alexius Health Bismarck in Bismarck, North Dakota, part of CommonSpirit Health.

Dr. Battista's NPI, 1528470135, was assigned on May 30, 2014. Dr. Battista holds North Dakota license 16735.

Dr. Battista's primary practice is CHI St. Alexius Health Bismarck, at 900 E Broadway, Bismarck, ND 58501 in Burleigh County. The practice phone is (701) 530-7000.

Dr. Battista's primary practice is CHI St. Alexius Health Bismarck in Bismarck, North Dakota, part of CommonSpirit Health. Dr. Battista is also affiliated with Essentia Health-Fargo. The medical group on file is Essentia Health-Fargo. Dmand AI also links Dr. Battista to 1 more hospital, 1 behavioral health center, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Battista practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Battista's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Battista's licenses on file in 2 states: North Dakota and Michigan.

CMS data shows 258 Medicare services from Dr. Battista across 9 procedure codes in 2024, for 217 Medicare patients. Medicare paid $21,546 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 217 Medicare patients who saw Dr. Battista in 2024. The largest group is 65 to 74, with 86 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.09, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Battista's median patient age at 61, with 54% women.

In 2024, Dr. Battista wrote 348 Medicare Part D claims for 144 patients. 76% of them were for generic drugs. CMS names the drug for 240 of them, across 7 drugs with 11 or more claims each, at $15,365 in total drug cost. In 2023, CMS named 293 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Battista for performance year 2024, reported as part of a group. Dr. Battista accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Battista as offering telehealth. CMS counts 93 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Battista, more than 75% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Battista in 2019. 2019 was the busiest year, with 2. Dr. Battista's most frequent co-authors are Douglas Graham Adler, MD, Abdallah Haidar, MD and Christian E. Machado, MD.

CMS Open Payments shows 67 general payments to Dr. Battista from 26 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 95% of the total. Abbvie Inc. paid the most, $742.